• | For all unvested, outstanding equity held by Company employees (including the Named Executive Officers (“NEOs”) but excluding the Chief Executive Officer (the “CEO”)) as of May 24, 2016, the vesting of such equity was modified to occur on the earlier of: |
◦ | The normally scheduled vesting date provided for in the applicable grant agreement; |
◦ | The termination of an employee’s employment with the Company as a direct result of an announced sale, divestiture or spin-off of a subsidiary, division or other business unit of the Company (a “Corporate Transaction”); |
◦ | The termination of the employee’s employment by the Company without Cause (as defined in the Company’s Severance and Long-Term Incentive Change in Control Plan for Executive Officers Effective November 1, 2015 (the “SPEO”)); or |
◦ | Subject to the treatment of Performance Contingent Stock Options (“PCSOs”) discussed below, June 1, 2018 or such earlier date as determined by the CEO in consultation with the Human Resources and Compensation Committee (“HRC”) of the Board of Directors of the Company (the “Board”). |
• | For all unvested, outstanding equity held by the CEO as of May 24, 2016, the vesting of that equity was modified to occur on the earliest of: |
o | The normally scheduled vesting date provided for in the applicable grant agreement; |
o | Her retirement from the Company on a date reasonably determined by the CEO and the Board; or |
o | The involuntary termination of her employment by the Company without Cause (as defined in the SPEO). |
• | With regard to the PCSOs granted to all NEOs in December 2014, the share price component for all tranches was changed to $24.94 per share or higher for a period of 20 consecutive days occurring on or before December 10, 2017. |
• | With regard to the NQSOs and PCSOs granted to all NEOs other than the CEO, the terms were modified to provide that, upon (i) the earlier of (x) an involuntary termination of the NEO’s employment with the Company directly resulting from a Corporate Transaction or (y) termination of employment by the Company without Cause (as defined in the SPEO) , such awards will vest in full without regard to whether the share price component or other performance based requirements |
• | With respect to the Performance Adjusted Restricted Stock Units granted to all NEOs and outstanding as of May 24, 2016, the terms were modified such that they: |
◦ | Converted into time-vesting RSUs on November 30, 2016, based on the Company’s Fiscal Year 2016 ROIC (Return on Invested Capital) and Relative TSR (Total Shareholder Return) performance, to the extent outstanding on such date; |
◦ | Vest in accordance with the vesting schedule applicable to all equity outstanding as of May 24, 2016 (as described above); and |
◦ | Paid at target ROIC and target relative TSR if they vested before October 31, 2016. |